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Summary
The usefulness of cell lines in the study and predic-
tion of the clinical behaviour of lung cancer is still a
matter of debate. However, lung tumour cell cul-
tures have been of value in investigations concern-
ing molecular and cell biological aspects of these
neoplasms. Especially in the examination of
characteristics specific for the main types of differ-
entiation (squamous cell carcinoma, adenocarci-
noma, small cell carcinoma), in vitro studies have
been most important.
Twenty eight lung cancer cell lines were cultured
for up to four years, and were examined at regular
intervals for their intermediate filament protein
(IFP) expression patterns using a panel of cytokera-
tin (CK) and neurofilament (NF) antibodies. These
studies showed that the classic type of small cell
lung cancer (SCLC) cell lines contain CKs 8,18, and
occasionally CK 19, while the variant-type SCLC
cell lines generally express no CKs but can contain
NFs. Non-SCLC cell lines, such as squamous cell
carcinoma and adenocarcinoma cell lines, contain
CKs 7 (in most cases), 8, 18 and 19. In one variant
SCLC cell line and in one adenocarcinoma cell line
CKs 4, 10 and 13, characteristic of squamous cell
differentiation, were found. Although most cell
lines have remained stable with respect to growth
characteristics and IFP expression patterns, five
lung cancer cultures exhibited a transition from one
cell type to another, paralleled by changes in EFP
expression. Progressions from classic to variant
SCLC cell lines have been observed, next to conver-
sions from variant SCLC to cell lines re-expressing
cytokeratins. In some cases this resulted in a coex-
pression of CKs and NFs within a cell line and even
within individual rumour cells. These results
strongly support the earlier finding that CK ex-
pression in SCLC cell lines is a reliable marker for
the classic type of differentiation, while the absence
of CKs and the presence of NFs marks the variant
type of differentiation. Our results are discussed in
view of previous histological findings.
Key words: small cell lung cancer, cytokeratins,
neurofilaments.
Introduction
Intermediate filament proteins (IFPs) are cytoskeletal
components, which are expressed in a more or less tissue-
specific fashion and are, in most cases, retained during
neoplasia (Osborn & Weber, 1983; Ramaekers et al.
1983c, 1987a). In general, only one type of intermediate
filament protein is expressed in a certain tissue or
tumour. For instance, epithelial cells and carcinomas
normally express only IFPs of the cytokeratin (CK) type
(see, e.g., Ramaekers et al. 1983<i), while neuronal cells
and some neuronal tumours express only neurofilament
(NF) proteins (Altmannsberger et al. 1984). In normal
tissues, vimentin is in general found only in mesenchymal
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tissues.
However, in the last few years a growing number of
cases has been reported, in which a coexpression of two or
even three types of IFP within the same type of (tumour)
cells was demonstrated. Most frequently, if coexpression
occurs, vimentin is one of the IFPs present. Expression
of vimentin next to CK has been found in some normal
epithelial cells, such as human mesothelium and epithelia
from ovarium, amnion, endometrium, thyroid gland and
foetal kidney (Moll et al. 1983; Holthofer et al. 1984;
LaRocca & Rheinwald, 1984; Rheinwald et al. 1984;
Czernobilskyeta/. 1985; Regaueref a/. 1985; Achtstatter
et al. 1986). Also, in some types of primary carcinomas
coexpression of CKs and vimentin is seen (Caselitz et al.
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1981, 1984; Herman et al. 1983; Churg, 1985; Blobel et
al. 19856; Gould, 1985; Jasani et al. 1985; Upton et al.
1986), and this coexpression may also be seen in meta-
static carcinoma cells in body cavity fluids (Ramaekers et
al. 1983a). In carcinoma-derived cell lines the presence
of vimentin is a rule rather than an exception (cf. Franke
et al. 1979; Broers et al. 1985). Vimentin is expressed
next to desmin in muscle cell tumours (Molenaar et al.
1985).
More recently, coexpression of other types of inter-
mediate filaments has been reported. For instance,
Brown et al. (1987), Norton et al. (1987), van Muijen et
al. (1987) and Ramaekers et al. (1988) reported on the
coexpression of CKs and desmin in human foetal and
adult muscle tissue, and in smooth muscle tumours.
Kasper et al. (1986) showed the coexistence of CK,
vimentin and NF protein in human choroid plexus, while
Budka (1986) demonstrated a triple expression of glial
fibrillary acidic protein, vimentin and CK in papillary
meningioma and renal carcinoma. Gatter et al. (1986)
showed a double and triple expression of different IFPs
in many lung carcinomas. Coexpression of CKs and NFs
seems to be characteristic of some neuroendocrine tu-
mours, such as neuroendocrine skin carcinomas (Merkel
cell tumours; van Muijen et al. 1985; Gould et al. 1985;
Moll et al. 1986), parathyroid tumours (Miettinen et al.
1985), lung carcinoids (Lehto et al. 1985; Blobel et al.
1985a; Broers et al. 1987; Ramaekers et al. 1987a), some
small cell lung cancers (SCLCs; Gatter et al. 1986;
Broers et al. 1987) and (poorly differentiated) squamous
cell carcinomas (SQCs) of the lung (van Muijen et al.
1984; Broers et al. 1987). Also in a cell culture of a large
cell carcinoma of the lung (Bergh et al. 1984), in a
neuroendocrine skin carcinoma cell line (Rosen et al.
1987), in the neuroendocrine rat cell line PC12 (Frankeet
al. 1986) and in some SCLC cell lines (Bernal et al. 1983;
Banks-Schlegel et al. 1985; Gupta et al. 1986) coexpres-
sion of CKs and NFs has been reported.
The three major types of lung cancer comprise SCLC,
adenocarcinoma (AC) and SQC (W.H.O., 1982). In
addition, according to the latest IASLC classification,
SCLC can be subdivided into classic SCLC, variant
SCLC and combined SCLC (Yesner, 1985). It is now
generally accepted that lung cancer is an extremely
heterogeneous type of malignancy. On the basis of
detailed histological (Roggli et al. 1985), immunohisto-
chemical (Hammar e/ al. 1985; Dunnill & Gatter, 1986;
Broers et al. 1987, 1988) and electron-microscopic
(McDowell & Trump, 1981; Trump et al. 1982;
Dingemans & Mooi, 1984; Mooi et al. 1988) studies,
more than one type of differentiation can be detected in
the majority of lung cancers. Occasionally more than one
type of differentiation can be detected in cell lines, for
example in the so-called multipotent lung tumour cell
cultures (Carney et al. 1984; de Leij et al. 1985). Cloned
cells of these cell lines are apparently able to differentiate
again into the three major types of lung cancer within the
same culture. In addition, sometimes a conversion of one
cell type to another has been noticed. For example,
progressions of classic SCLC cell lines into the variant
type of SCLC cell line have been described (Bepler e< al.
1987a; Carney et al. 1984, 1985a,6; Gazdar et al. 1981,
1985; Graziano ef a/. 1987). Bepler elal. (1987a, 1988c)
described a transitional type of SCLC with features
between the classic and variant types.
Previous investigations in our laboratory on the inter-
mediate filament expression of classic and variant SCLC
cell lines have demonstrated the occurrence of CKs only
in classic SCLC cell lines, while in variant SCLC cell
lines no IFP or only NFs could be demonstrated (Broers
et al. 1985, 1986). In recent years, cell lines in which a
morphological change from one cell type to another could
be seen were examined for their IFP expression patterns.
Since different CK polypeptides are expresssed in
different types of lung cancer (cf. Blobel et al. 1984,
1985a; Broers et al. 1988), we paid special attention to
the CK polypeptide expression of these cell lines. Using a
panel of monoclonal CK antibodies, most of which are
specific for one CK polypeptide, it is possible to detect
SQC differentiation, AC differentiation and SCLC dif-
ferentiation at the cellular level (Broers et al. 1988).
In this paper we describe spontaneous changes in
intermediate filament patterns that can occur in lung
cancer cell lines, especially in SCLC cell lines. In part,
these alterations follow the phenotypic changes in the
tumour cells, and may be correlated with recent data
obtained with lung tumour tissues.
Materials and methods
Cell lines
Establishment and characterization of the cell lines used in this
study have been described (Carney et al. 1985a,b; de Leij et al.
1985; Gazdar et al. 1985; Bepler et al. 19876,c, 19886) or will
be described elsewhere. In all, 19 SCLC cell lines were
investigated (NCI-H69, NCI-H128, NCI-H449, NCI-N417,
NCI-H524 and NCI-H82; GLC1-M13, GLC-1, GLC-2,
GLC-3, and GLC-5; SCLC-16HC, SCLC-16HV, SCLC-21H,
SCLC-22H, SCLC-24H, and SCLC-86M1; NL-SCLC2 and
NL-SCLC3). Next to these, one LCLC cell line (LCLC-
103H), six AC cell lines, (NCI-H23, NCI-H125, GLC-A1,
GLC-A2, GLC-A3, NL-AC1) and two epithelial cell lines
derived from SQCs (EPLC-32M1 and EPLC-65M2) were
used.
All cell lines were maintained in a humidified incubator at
37°C in 5 % CO2 and were grown in Roswell Park Memorial
Institute Medium 1640 (RPMI-1640, Flow, Irvine, UK) con-
taining Hepes, supplemented with 15 % newborn calf serum
(Flow). At regular intervals cells were passaged by splitting
cells 1:2 to 1:3. If cells tended to attach to the culture flasks, the
adhering cells were selected by removing the floating cells. As a
result sublines NCI-N417-A1, NCJ-N417-A2, NCI-H524-A
and NCI-H82-A were obtained.
Indirect immunofluorescence technique
The procedures for the application of the indirect immunoflu-
orescence technique have been described (Broers et al. 1986).
In brief, floating cells were placed on glass slides using a
Cytospin centrifuge (500 revs inin"1 for lOmin; Shandon
Southern Instruments, Astmoor, Cheshire, UK), while cells
growing attached to the culture flasks were treated with 005 %
trypsin/002% EDTA in 0-05 M-phosphate-buffered saline
(PBS), pH 7-4, and allowed to grow on glass coverslips for 1-2
days. In the first step, cells were incubated with the primary
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antibody (see below) for 30—45 min. As second antibody, either
fluorescein isothiocyanate (FITC)-conjugated rabbit anti-
mouse IgG (1:25, Nordic, Tilburg, The Netherlands) or
FITC-conjugated goat anti-rabbit IgG (1:25, Nordic) was
applied to the cells for 30-45 min.
In the double-label immunofluorescence technique a mixture
of two primary antibodies (one raised in mouse and one in
rabbit) was applied in the first step. Cells were incubated for
30-45 min and, after washing with PBS, a mixture of FITC-
conjugated goat anti-rabbit IgG and Texas Red-conjugated
sheep F(ab')2 anti-mouse IgG (Amersham, Bucks, UK) with
final dilutions of 1:25 and 1:50, respectively, was added. Cells
were incubated for 30—45 min, and washed again. DNA was
then stained by incubating the cells for 15 min with Hoechst
33258 (0-1/igml"1 in 22mM-citric acid, 56mM-disodium hy-
drogen phosphate). After washing with PBS the cells were
mounted. Pictures were taken with an automatic camera, with
either a 400 ASA Tri-X film (Kodak) or with a 400 ASA
Ektachrome film (Kodak) for triple exposures at three different
wavelengths. Overlap between the FITC and Texas Red
fluorescence at the respective wavelengths was checked using
preparations labelled with a single second antibody. Incu-
bations with the second antibodies alone were used as negative
controls.
Antibodies
Specificity and references of the primary antibodies used in this
study are summarized in Table 1. The following primary
antibodies were used.
Mouse monoclonal CK antibodies (undiluted). (1) RCK102
is a broadly cross-reacting CK antibody of the IgGl subclass,
which recognizes CKs 5 and 8, and as a result stains virtually all
epithelial tissues (Ramaekerse/ al. 19876). (2) RCK105 (IgGl;
Ramaekers ef al. 19876) reacts only with CK 7 in immunoblot-
ting and stains a subgroup of glandular epithelia and their
tumours, next to transitional bladder epithelium and bladder
carcinomas. (3) RGE53 (IgGl; Ramaekers el al. 19836, 1985)
and RCK106 (IgGl; Ramaekers el al. 19876) are monospecific
for CK 18 in immunoblotting. In general these two antibodies
recognize columnar epithelial cells from digestive, respiratory
and urogenital tracts, endocrine and exocrine tissues and
mesothelial cells, as well as their tumours. Generally, no
reaction is found in squamous epithelia or SQCs. (4) LP2K
(Lanee/a/. 1985) and BA17 (IgGl; Barteke/n/. 1986fl,6) stain
most simple epithelia and basal cells in stratified squamous
epithelia that are not keratinizing. Both antibodies recognize
only CK 19 in immunoblotting assays. (5) RKSE60 (IgGl;
Leigh el al. 1985; Puts el al. 1985) reacts only with keratinizing
epithelial cells, and recognizes CK 10 in immunoblotting. (6)
6B10 (IgGl; van Muijen e< al. 1986) reacts with non-cornifying
squamous epithelium and with certain ciliated pseudostratified
epithelia such as cylindrical epithelium of bronchi, and recog-
nizes only CK 4 in immunoblotting. (7) Antibodies 1C7
(IgG2a; van Muijen et al. 1986) and 2D7 (IgG2b; van Muijen
el al. 1986) react both with non-cornifying squamous epithelia.
These antibodies recognize only CK 13 in immunoblotting
studies.
NF antibodies. (1) The mouse monoclonal antibody MNF
(IgG 1, diluted 1:5 in PBS), is reactive with the 68x10*Mr and
200X 103Mr NF subunits and stains neuronal tissues and
tumours (Kluck el al. 1984). (2) The polyclonal rabbit NF
antibodies pNF68 (diluted 1:400), pNF160 (diluted 1:600)
and pNF200 (diluted 1:400) are specific for the three NF
subunits of 68, 160 and 200(Xl03)Mr, respectively (Nakazato
el al. 1984), and react in neuronal tissues.
Vimentin antibodies. (1) The mononclonal antibody RV202
(IgGl; Ramaekers el al. 19876) reacts with mesenchymal cells.
(2) The polyclonal antibody pVIM prepared against bovine lens
vimentin (Ramaekers et al. 1983c) also reacts with mesenchy-
mal cells.
Antibodies RCK102, RCK105, RGE53, RKSE60, MNF,
6B10, 1C7, 2D7, and pVIM are available from Euro-Diagnos-
tics B.V. (Apeldoorn, The Netherlands).
Gel electrophoresis and immunoblotting
For gel electrophoresis and immunoblotting experiments the
same procedures were followed as described (Broerse/ al. 1986,
1988). For immunoblotting the following antibodies were used:
RCK102 (undiluted supernatant), RCK105 (undiluted super-
natant), RCK106 (undiluted supernatant), LP2K (diluted
1:10) and pNF68 (diluted 1:5000).
Table 1. Specificity of antibodies used in this study
Mouse Ig subclass Antigen
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p, polyclonal (rabbit) antisurum. NF, neurofilamcnts; K, \(PAJr.
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Flow cy tome try
The preparation of cell samples for flow cytometric analyses has
been described (Ramaekers et al. 1986). Briefly, cells were
centrifuged at room temperature (5 min, 500 g) and the super-
natant was discarded, but fluid sticking to the wall of the tubes
was allowed to cover the pellet. Cells were resuspended in this
fluid by vigorously vortexing, cold ( —20°C) 70% ethanol was
added, and the cells were kept in this solution until staining.
The final cell concentration was about 10 cells per ml of 70 %
ethanol. Approximately 106 cells were taken from this suspen-
sion and stained for DNA with propidium iodide according to
Feitz et al. (1985), and for CKs using the antibody RCK102 as
described (Ramaekers et al. 1986).
Cell analysis was performed using a Cytofluorograph 50H
(Ortho Instruments, Westwood, MA, USA). Propidium iodide
was excited at 488 nm and fluorescence was measured using a
630 nm longpass filter. For determination of the DNA index
chicken red blood cells served as an internal standard and
human lymphocytes as an external standard (Jakobsen, 1983).
Results
Expression of cytokeratins, neurofilaments and
vimentin
The expression patterns of CKs, NFs and vimentin in
lung carcinoma cell lines as detected by the indirect
immunofluorescence technique are shown in Table 2.
The CK expression patterns are depicted in Fig. 1.
Within the SCLC cell lines a subdivision can be made
between the classic SCLC cell lines, which contain CKs
but not vimentin or neurofilaments, transitional SCLC
cell lines with a variable CK expression pattern and the
expression of vimentin, and the variant SCLC cell lines,
which in general do not contain CKs but contain vimen-
tin and have a variable expression of neurofilaments. In
all classic SCLC cell and in most transitional SCLC cell
lines a positive staining reaction was observed with the
broadly cross-reacting RCK102 antibody (CKs 5 + 8;
Fig. 1A,B,C). Also in the large cell lung cancer (LCLC),
the AC (Fig. ID) and the SQC cell lines a strong staining
reaction was seen with this antibody. Antibodies to
stratified squamous cell epithelia, reacting with CK 4, 10
or 13, were reactive with two cell lines. One of these cell
lines (GLC-3) was derived from a SCLC, which at the
electron-microscopic level showed next to SCLC also AC
differentiation, while the CK expression patterns indicate
squamous cell differentiation. The other cell line (GLC-
A2) was derived from an AC of the lung. The expression
of CKs 4, 10 and 13 in this cell line clearly shows
squamous cell differentiation, next to AC differentiation
(a positive reaction with the CK 7 antibody). The classic
SCLC cell lines reacted in general in most cells with the
antibodies to CK 19 (Fig. 1E,G), while the transitional
SCLC cell lines reacted only in part of the cells or not at
all (Fig. IF) with these antibodies. In non-SCLC cell
lines a reaction pattern varying from only a weak reaction
in some cells to a very strong reaction in all cells
(Fig. 1H) was seen with the CK 19 antibodies. The
monoclonal antibodies to CK 18 reacted with all classic
(Fig. II,K), three out of four transitional (Fig. 1J) and
three variant SCLC cell lines, and a strong reaction with
all non-SCLC cell lines could be observed (Fig. 1L).
The antibody to CK 7 reacted with only one out of 19
SCLC cell lines in some of the tumour cells
(Fig. 1M,N,O), while in contrast all but one of the non-
SCLC cell lines were positive with this antibody
(Fig. IP).
Neurofilaments were present in seven out of ten variant
SCLC cell lines. A filamentous staining reaction was not
seen in the other types of SCLC cell lines with the NF
antibodies. In only one out of nine non-SCLC cell lines
was a reaction seen with the NF antibodies.
Vimentin was expressed in variable amounts, ranging
from no reaction in the classic SCLC cell lines (see also
Broers et al. 1985, 1986) to a strong filamentous staining
reacting in adherent growing cells of most AC cell lines.
Our immunofluorescence findings on the CK ex-
pression in lung cancer cell lines were confirmed using
the immunoblotting technique. Fig. 2 shows the results
of one-dimensional immunoblotting assays of an AC cell
line (A) and two classic SCLC cell lines (B). For
comparison, the same nitrocellulose blots were sub-
sequently incubated with different CK antibodies. Using
LP2K, the presence of CK 19 could be demonstrated in
the AC cell line (A, lane 1) and in one classic SCLC cell
line (B, lane 2). CKs 8 and 18 were present in all three
cell lines as detected by antibodies RCK102 and
RCK106, respectively (A, lane 2; B, lanes 3,4) . Appli-
cation of the CK 18 antibody RCK106 alone showed the
presence of large amounts of CK 18 in the AC cell line (A,
lane 3) as compared to a weak reaction in the two SCLC
cell lines (B, lanes 5, 6). When applying the CK 7
antibody on these blots, an additional band was seen in
the AC cell line (A, lane 4) but not in the SCLC cell lines
(B, lanes 7, 8). Probably owing to breakdown of CK
polypeptides, a phenomenon often occurring as a result
of (limited) proteolysis by an endogenous protease (see
also Schiller & Franke, 1983), additional bands can be
seen, which are denoted by arrows. In immunoblotting
Fig. 1. Expression of cytokeratins (CKs) in classic small cell
lung cancer (SCLC) cell line GLC1-M13 (A,E,I,M),
transitional SCLC cell line SCLC-24H (B,F,J,N), classic
SCLC cell line NCI-H449 (C,G,K,O), and in
adenocarcinoma (AC) cell line NCI-H125 (D,H,L,P) as
monitored by (chain-specific) monoclonal antibodies in the
indirect immunofluorescence technique. A strong filamentous
reaction pattern is seen with the broadly cross-reacting
antibody RCK102 in all classic and most transitional SCLC
cell lines (A, X460; B, X400; C, X460), and in all AC cell
lines (D, X300). A variable reaction pattern is seen in SCLC
cell lines using LP2K, specific for CK 19, showing a clearly
filamentous staining reaction in the classic SCLC cell lines
(E, X36O; G, X410), while no reaction is seen in the
transitional SCLC cell line (F, X460). A strong reaction is
seen with LP2K in the AC cell line (H, X300). All CK
positive SCLC cell lines contained CK 18 as demonstrated
with RCK106 (I, X460; J, X410; K, X460), while also the
AC cell line showed a strong reaction with this antibody (L,
X300). In SCLC cell lines no reaction was seen with the CK
7 antibody RCK105 (M, X460; N, X410), except for cell line
NCI-H449, in which part of the cells showed a positive
reaction (O, X460). Most cells of the AC cell line showed a
strong staining reaction with RCK 105 (P, X300).
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studies of variant SCLC cell lines no CKs could
demonstrated (results not shown).
be
Coexpresswn of cytokeratins and neurofilamenls
Cell line GLC-Al was derived from an AC of the lung. In
contrast to other AC cell lines (see Table 2), very few of
its cells react with the CK 7 antibody, and many cells do
not seem to contain any CKs at all. Fig. 3A shows that
some cells of GLC-Al react with RCK102, while others
do not. In addition, an expression of NF proteins can be
seen in some of the tumour cells (Fig. 3B). Quantifi-
cation of labelled cells showed a reaction with RCK102 in
about 7 % of all cells, and a reaction with the pNF160
antibody in about 30%. Approximately 5 % of all cells
showed a coexpression of CKs and NFs, i.e. reacting
Intermediate filaments in lung cancer 95












































































































/— Some c. Some c. Some c.
Some c.
Dot-like
+ + , strong reactivity in all cells; + , reactivity in more than 90% of all cells; + / —, reactivity in part of the cells (10-90%); Some c , reactivity in less
than 10% of all cells; Dot-like, a dot-like reaction in a small part of all cells; - , no reaction in any cells.
• (5+8) , CK polypeptidc(s) recognized according to the catalogue of Moll et at. (1982).
with RCK102 and with pNF160 in the same cells.
Double immunofluorescence staining showed that some
cells clearly coexpress CKs and NFs (compare Fig. 3C
and D, E and F), while other cells express only NFs and
no CKs (Fig. 3C,D). Staining of cell nuclei in the
immunolabelled preparations (Fig. 3G) showed that
most cells in the GLC-A1 culture do not express IFPs of
the CK or NF type. Fig. 4 shows the expression of CKs
(red fluorescence) and NFs (green fluorescence) in differ-
ent cells of the GLC-A1 culture, with cell nuclei stained
blue. The micrograph clearly shows the coexistence of
cells expressing different IF types in this culture.
GLC-5 was initiated from a lymph node metastasis of a
SCLC expressing NFs next to CKs (de Leij et al. 1986).
In early passages of this cell line only NFs were found,
while in later passages a coexpression of CKs and NFs
was seen again. Subcloning of GLC-5 did not result in a
separation of CK or NF positive cells, but after some
time each cloned population contained cells positive for
NFs and few cells positive for CKs. Cells expressing CKs
had the morphological appearance of classic SCLC cells,
i.e. growing in very tight clusters of floating cells, while
most of the cells expressing NFs grew as loose clusters,
which tended to attach to the surface of culturing flasks.
Transitions of IFP patterns within SCLC cell lines
Subcloning of the variant SCLC cell line GLC-1 resulted
in cell line GLC1-M13, having biochemically classic
SCLC properties (de Leij et al. 1985) and expressing
CKs in nearly all tumour cells (Fig. 1). The variant
SCLC cell line GLC-1, however, does not express any
CKs (Broers et al. 1985; de Leij et al. 1985; Tables 2,3).
One of the SCLC cell lines, i.e. SCLC-16H, was
initially characterized as a classic SCLC cell line (Bepler
et al. 19876,c) and later reclassified as a transitional
SCLC cell line (Bepler et al. 19886). After about one year
of culturing (approximately 65 passages) this cell line had
lost its transitional SCLC morphology and expression of
L-dopa decarboxylase activity (Bepler et al. 19876). An
early passage of this cell line (SCLC-16HCp39, Table 3),
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Fig. 2. One-dimensional immunoblotting assays using different chain-specific CK antibodies on cytoskeleton preparations from
an AC cell line (NCI-H125; A), and from the two classic SCLC cell lines NL-SCLC2 (B, lanes 1, 3, 5, 7) and NCI-H69 (B,
lanes 2, 4, 6, 8). On the basis of Coomassie Brilliant Blue staining patterns, comparable amounts of cytoskeletal proteins from
each sample were applied. Immunoblotting with the antibody LP2K gave a band at the CK 19 level in the AC cell line (A, lane
1), and in the SCLC cell line NCI-H69 (B, lane 2). Subsequent incubation of the same immunoblots with a CK 18 antibody
RCK106 and with RCK102, recognizing CKs 5 and 8, resulted in the appearance of bands at the level of CKs 18 and 8,
respectively, in the AC cell line (A, lane 2), whereas in the SCLC cell lines a relatively strong band was detected in both cell
lines at the CK 8 level. A much weaker reaction was seen at the CK 18 level (B, lanes 3 and 4). Incubation with RCK106 alone
resulted in a strong reaction in the AC cell line (A, lane 3) and a weak, but evident reaction in the two SCLC cell lines at the
CK 18 level (B, lanes 5 and 6). A subsequent incubation of these immunoblots with the antibody RCK10S gave an additional
band at the CK 7 level in the AC cell line (A, lane 4), but not in the classic SCLC cell lines (B, lanes 7 and 8). Note the
prominent bands in the AC cell line (denoted by arrows) representing breakdown products of CKs 18 and 19.
with typical transitional SCLC properties, showed the
expression of CKs in most cells (Fig. 5A) and the absence
of NFs (Fig. 5B). Some cells, however, showed a dot-like
reaction pattern with the pNF68 antibody (Fig. 5C). A
late passage of this cell line (SCLC-16HVp93), which
was biochemically characterized as a variant SCLC cell
line (Bepler el al. 19876), did not express any CKs
(Fig. 5D), but showed the presence of NFs in about 10 %
of the cells (Fig. 5E).
Cell line NCI-N417 did not seem to express CKs or
NFs when introduced in our laboratory (Fig. 6A,B; see
also Broerse/ al. 1985, 1986). However, when grown for
more than 6 months in the same culture flask with regular
changes of the culture medium, a subset of cells arose
(NCI-N417-A1) that grew firmly attached to the plastic.
These cells appeared to express CKs (Fig. 6D,E), while
some of the remaining floating cells of NCI-N417 showed
a dot-like reaction with the CK 18 antibody RCK106
(Fig. 6C), but not with other CK antibodies. After
several passages the formerly adhering cells were no
longer attached, and the CK-positive subset of cells was
lost. After another 6 months again some cells attached to
the surface of the culture flasks (NCI-N417-A2). Both
the floating and the attached cells now revealed a positive
staining reaction with NF antibodies in about 10 % of all
cells (Fig. 6F,G).
A comparable switch in IFP expression was noticed in
cell line NL-SCLC3. In frozen sections of the SCLC
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Fig. 3. Immunofluorescence staining patterns of cell line GLC-Al derived from an AC of the lung. Part of the cells react
strongly with RCK102 (A, X38S), while also a strong reactivity is seen with the pNF160 antibody (B, X450). Double-label
immunofluorescence studies (C-F) show that cells that are reactive with RCK102 (C, asterisk; X450) are also stained by the
pNF160 antibody (D, X4S0). In addition, some cells that do not react with RCK102 are positive with the pNF160 antibody
(D). Double-label inimunofluorescence in combination with nuclear DNA staining with Hoechst (E,F,G) shows that also cells
reactive with RCK106 (E, X3S0), may react with the pNF160 antibody (F, X350), while the distribution of fluorescence
suggests colocalization of the two filament systems. The nuclear DNA staining (G, X3S0), however, shows that most cells of
this sample do not contain CKs of NFs.
from which this cell line was derived, no CKs or NFs
could be detected in the tumour cells. The same holds
true for the cell line up to passage 7. However, at passage
10 a small subset of cells was found that expressed NF
proteins. With each subsequent passage the percentage of
cells positive for NFs increased to about 50% at passage
20.
Another type of change in IFP expression was seen in
the variant SCLC cell lines NCI-H524 (Fig. 7) and NCI-
H82 (Fig. 8). These cell lines normally grow as loosely
packed floating aggregates, which do not attach to the
bottom of culturing flasks, and express NFs in all cells
(Figs 7D, 8A). CKs can not be detected in these floating
cells (Figs 7E, 8B). After a prolonged period of growing
in the same culture flask, however, an increasing number
of cells attached to'the bottom (see, e.g., Fig. 7A,B,C).
Immunofluorescence studies showed that these adhering
cells not only lost their NF expression in part of the cells,
but also that some of these cells initiated the
(co-)expression of CKs (Figs 7F,G and 8C,D). Double
immunofluoresence studies showed that in NCI-H524
some cells coexpress NFs and CKs, while other cells
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Fig. 4. Triple exposure of cell line GLC-Al after incubation with RCK102 visualized with sheep anti-mouse Texas Red,
pNF160 visualized with goat anti-rabbit FITC, and a nuclear DNA staining with Hoechst. Note the presence of cells containing
only CKs (red fluorescence), the presence of cells containing only NFs (green fluorescence), and a possible coexpression of CKs
and NFs in a third group of cells (yellow fluorescence, arrows); X650.
Fig. 9. Triple exposure of a double-label immunofluorescence experiment, with additional nuclear DNA staining of NCI-H82
(X650). Note the expression of CKs, reacting with RCK102 (red fluorescence) and the staining of NFs with the pNF160
antibody (green fluorescence). The yellow colour seen in some cells (arrows) is probably caused by the colocalization of CK and
NF containing filaments.

















(10) MNF pNF68 pNF160
 PNF200 RV202 pVim
GLC-1 - - _ _ _ - _ _ _ _ _ + +
GLC-1-M13 + - + / - + / - - - _ _ _ _ _ _ _
SCLC-16HC + / - - + / - + / - - - - - Dot-like - - + / - + / -
SCLC-16HV - - _ _ _ _ _ + /_ + /_ + / _ + / _ + / _ +/_
NCI-N4I7 - - Dot-like _ _ _ _ _ _ _ _
 + / _ +/_
NCI-N417-AI + + - + + + + - - - - - + + + +
NCI-N4I7-A2 - - - - + / - + / - + / - + / - + / - + / -
NL-SCLC3pl - - - _ _ _ _ _ _ _
NL-SCLC3plO - - » - - - - + / - + / - + / - + / - + / - + / -
NC1-H524 - - - - - - + + + + - + / - + / -
NCI-HS24-A + / - ->• + / - — -r « - « + / ~ *./-• - + / - + / -
NC1-1I82 - - - - - + + + + + + + + + / - + / -
NCI-H82-A + + - + + - - - - + / - + / - + / - + / - + +
+ + , strong reactivity m all cells; + , reactivity in more than 90 % of all cells; + / —, reactivity in part of the cells (10-90%); Dot-like, a dot-like reaction
m a small part of the cells; —, no reaction in any cells.
•(5 + 8), CK polypcptide(s) recognized according to the catalogue of Moll el at. (1982).
Fig. 5. Imniunofluorescence staining patterns of SCLC-16H at an early passage number (p39; A,B,C) and at a late passage
number (p93; D,E). During early passages most cells reacted strongly with the CK antibody RCK102 (A, X450). Most cells
did not react with the pNF68 antibody (B, X475), while in some cells a dot-like reaction pattern with this antibody was seen
(C, X450). In the late passages all cells have lost CK expression (D, RCK102; X4S0), while in about 10% of all cells a reaction
with NF antibodies was found (E, pNF200; XS50).
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Fig. 6. Immunofluorescence staining patterns of NCI-N417 with (apparently) three different types of differentiation. Initially,
this cell line did not express CKs, showing no reaction with RGE53 (A, X360). Also no NFs were detectable with pNF200 (B,
X175). After prolonged culturing some cells started to attach to the culturing flask (C,D,E). At this stage some floating cells
started to express CKs, a reaction with RCK106, in a dot-like manner (C, X475). Cells that grew firmly adherent all contained
CKs, reacting with RCK106 (D, X410) and with RCK102 (E, X435). Upon culture, CK positive cells were lost, while some
cells started to express NFs, which were reactive with the pNF68 antibody (F, X47S) and with the pNF200 antibody (G,
X475).
express only NFs (cf. Fig. 7H,I). The same phenom-
enon can be observed in NCI-H82, where some cells
express CKs (Fig. 8E,H) and other cells express NFs
(Fig. 8F,I), while occasionally a clear coexpression of
CKs and NFs can be observed (cf. Fig. 8H,asterisk, I).
Counterstaining of the nuclear DNA with Hoechst shows
that most cells in NC1-H82 express either CKs or NFs
(Fig. 8G,J). Coexpression of CKs and NFs is also clearly
seen in Fig. 9, in which CKs are stained in red and NFs
in green. The yellow colour may indicate colocalization of
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Fig. 7. Phase-contrast (A-C) and immunofluorescence (D-G) micrographs of the variant SCLC cell line NCI-H524. At first,
this cell line grew as floating aggregates (A, X 105) with cells expressing NFs, showing a reaction in all cells with, for example,
the pNF160 antibody (D, X475). No cells could be detected to be positive for CKs (E, RCK106; x360). Upon culturing, an
increasing number of cells started to grow adherent (B, X235; C, X105). These adherent cells clearly expressed CKs, showing a
reaction with RCK102 (F, X435) and with RCK106 (G, X435). Double-label immunofluorescence experiments (H,I) show that
some cells that were reactive with the pNF160 antibody (H, X47S) also reacted with RCK102 (G, X475).
Intermediate filaments in lung cancer 101
CKs and NFs in certain cells.
Our immunofluorescence data were confirmed by im-
munoblotting experiments using RCK106 as a marker for
CK expression and pNF68 as a NF marker (Fig. 10); A
shows two weakly stained protein bands at the level of
CK 18 (lane 1) and the somewhat stronger reaction with
the 68x 103il/r NF protein (lane 2) in GLC-A1, and in B
the early passage (p39) of SCLC-16HC was compared
with a late passage (p93) of this cell line (SCLC-16HV).
Lane 1 shows the presence of CK 18 in SCLC-16HC,
while SCLC-16HV (lane 2) does not show a reaction with
RCK106. Subsequent incubation with the pNF 68 anti-
body (lanes 3, 4) does not result in extra bands, probably
due to the low number of cells expressing NFs in SCLC-
102 J . L. V. Brunts el ul.
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Fig. 10. One-dimensional immunoblotting of different lung cancer cell lines. A. Cell line GLC-A1 shows a faint (double) band
at the 45xl03iV/r level with the CK 18 antibody RCK106 (lane 1). This weak reaction can be explained by the fact that CKs
were detected in only 7% of all cells in immunofluorescence experiments. After subsequent incubation of the same immunoblot
with the pNF68 antibody a stronger reaction is seen at the 68xlO3Mr level (lane 2). B. Early passage of SCLC-16HC (passage
39; lanes 1, 3) compared with a late passage (SCLC-16HV, passage 93; lanes 2, 4) of this cell line. SCLC-16HC shows a clear
reaction with RCK106 (lane 1), while no reaction is seen with RCK106 in SCLC-16HV (lane 2). Incubation of the same blot
with pNF68 did not result in an additional band at the 68xlO3/V/r level in either cell line, confirming the immunofluorescence
data of SCLC-16HC with this antibody. A discrepancy is seen with the positive immunofluorescence reaction with pNF68 in
SCLC-16HV, which might be explained by the low number of cells reacting with this antibody. C. Adherent growing culture of
the variant SCLC cell line NCI-H524, incubated with RCK106 (lane 1) and subsequently incubated with pNF68 (lane 2). Note
the presence of the CK 18 band and the 68xlO3Mr NF band in this cell line. D. Comparison of the floating (lanes 1, 3) and the
adherent growing cells (lanes 2, 4) of the variant SCLC cell line H82. Incubation with RCK106 results in a reaction at the
45xlO3/V/r level with the adherent growing cells only (compare lanes 1, 2), while subsequent incubation with pNF68 shows that
both cell types contain the 68xlO3/V/r NF polypeptide.
Fig. 8. Immunofluorescence staining patterns of the variant
SCLC cell line NCI-H82. This cell line, growing as floating
aggregates, expressed NFs (A, pNF160; X310) and did not
express CKs (B, RCK106; X420). However, after prolonged
culturing some cells started to grow adherent, and selection of
these cells resulted in a cell culture that was clearly positive
with different CK antibodies, such as RCK102 (C, X460)
and RCK106 (D, X410). Double-label immunofluorescence
studies (compare E,F,G, with H,I,J) showed that within this
cell culture some cells expressed CKs, reactive with RCK102
(E, X410; H, X345), while other cells were reactive with the
pNF200 antibody (F, X410) or with the pNF68 antibody (I,
X345). Nuclear DNA staining (G, X410; J, X345) showed
that most cells were reactive with either CK or NF
antibodies, while in one cell probably a coexpression of CKs
and NFs was seen (compare H,I,J; asterisk).
16HV. Fig. IOC shows the presence of CK 18 (lane 1)
and of the 68x 103A/r NF protein (lane 2) in the subset of
cells from NCI-H524 that grows as an attached mono-
layer. Fig. 10D shows the differences between CK and
NF expression in the floating and the attached sublines of
NCI-H82. Incubation with the CK 18 antibody shows
the presence of this protein in the adherent cells (lane 2)
and no reaction in the floating cells (lane 1). Subsequent
incubation with the NF antibody shows that both cell
types express the 68xl03iWr NF protein (lanes 3, 4).
Monitoring of cross-contamination
To detect whether changes within cell lines might be due
to possible cross-contamination with other cell lines
simultaneously growing in our laboratory, flow cyto-
metric analyses were performed at regular intervals. As
an example, Fig. 11 shows the flow cytometric analysis of
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Fig. 11. Comparison of flow cytometric analyses of floating (A) and adherent growing (B,C) cells of the variant SCLC cell line
NCI-H524. The DNA indices (DI) found for both cell types did not differ significantly. C. Two-parameter flow cytometric
analysis of cells from B separated according to their cytokeratin (CK) content, as determined with RCK102 (labelled with rabbit
anti-mouse FITC), and DNA content as determined by labelling with propidium iodide. It was calculated that about 15 % of
the adherent cells of NCI-H524 were positive with RCK102.
the floating fraction of NCI-H524, as compared with the
adherent growing fraction of this cell line. No significant
shift in DNA index (DI), nor extra DNA peaks, indi-
cating a possible contaminating cell line, were observed
(cf. Fig. 11A,B). The DI value of both cell lines varied
between 1-10 and 1-23. In addition, the attached fraction
was labelled with the CK antibody RCK102 and analysed
in a two-dimensional fashion, in which DNA was stained
with propidium iodide. The results show that about IS %
of the adherent cells contained CKs (Fig. 11C). Floating
cells did not contain CKs (not shown).
The DI values of the two adherent growing variant
SCLC cell lines (NCI-H82, DI = 1-20-1-22; NCI-
H524, DI = 1-10-1-23) were compared with those for
other adherent growing lung cancer cell lines such as
EPLC-32M1 (DI = l-50), EPLC-65M2 (DI = l-55),
LCLC-103 (DI = 3-27), NCI-H23 (DI = l-60), NL-
AC1 (DI = 1-52), and non-lung cancer epithelial cell
lines growing in our laboratory, such as T24 (DI = 1-57)
and HeLa (DI = l-48). Since the DI values for the
Go/G] cells of these cell lines are all significantly higher
than 1-23, a cross-contamination with these cell lines can
be excluded. In addition, the CK and NF expression
patterns of the adherent growing variant SCLC cell lines
appeared to be unique for these two cell lines.
Discussion
In this paper we describe changes in IFP expression in
lung cancer cell lines during long-term culture. We have
especially focused on CKs and NFs, since it is known that
classic and variant SCLC cell lines exhibit different
expression patterns of these IFPs (Broers et al. 1985,
1986).
In the last decade lung carcinoma cell lines that have
retained many characteristics of the in vivo cancers have
been established (Gazdar et al. 1981, 1985; Bergh et al.
1984; Carney et al. 1984, 1985a,6; Beplere/a/. 19876,c,
19886). Most of these cell lines form tumours when
injected into athymic nude mice with a histology similar
to that of the original malignancy. Banks-Schlegel et al.
(1985) stated that cell lines derived from different types
of lung tumours continue to maintain a program of CK
expression reflective of the native tumour.
Cytokeratins and neurofilaments in lung cancer cell
lines
Our results on the IFP expression patterns in lung cancer
cell lines are partly in accord with the findings in solid
lung carcinomas with homogeneous morphology (Broers
et al. 1988). In general, one can state that classic and
transitional SCLCs and ACs contain CKs typical of
simple epithelia, i.e. CKs 8, 18 and sometimes 19. In
addition to these CKs, AC cell lines are characterized by
the presence of CK 7, which is absent in SCLC. Variant
SCLC cell lines in general do not contain CKs but may
express NFs (see also Broers et al. 1985, 1986). Some
exceptions, however, were seen.
(1) Two cell lines derived from SQCs (EPLC-32M1
and EPLC-65M2) did not express the typical SQC CKs,
i.e. CKs 10 and 13, but contained CKs 7, 8 and 18,
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occurring in simple epithelia, in this way resembling
poorly differentiated SQC in their expression pattern (see
also Broers e/ al. 1988). These changes are in accord with
histological findings in mouse xenografts, in which these
tumours were classified as undifferentiated large cell
carcinomas (Beplere* al. 19886). Furthermore, Blobelei
al. (1984) have already shown that other cell lines derived
from SQC mainly express CKs 7, 8 and 18.
(2) On the other hand, a cell line derived from an AC
(GLC-A2) did express CKs 10 and 13, characteristic of
SQC as well as CKs 7, 8 and 18, characteristic of ACs.
(3) Another cell line derived from an AC (GLC-A1)
expressed NFs next to CKs, while CK 7, characteristic of
ACs of the lung (see also Broers et al. 1988), was present
in only a few cells of this culture. Therefore, on the basis
of IFP expression patterns, this cell line resembles
variant SCLC cell lines rather than AC cell lines.
(4) One of the SCLC cell lines (GLC-3) exhibited
SQC differentiation as concluded from its IFP expression
pattern. Interestingly, this cell line was previously shown
to express AC differentiation characteristics at the elec-
tron microscopic level (de Leij et al. 1985).
These data clearly demonstrate heterogeneity within
some cell lines in both degree and type of differentiation.
However, results from most other cell lines show that
cultured SCLC lines may serve as suitable models with
which to study the biology of lung carcinoma subtypes
(see also Gazdar & Minna, 1986).
Transitions in IFP expression patterns
In earlier studies, changes in growth pattern were ob-
served during prolonged culturing of lung cancer cell
lines; for instance, progression of classic to variant SCLC
cell lines has been reported by several authors (Gazdar et
al. 1981, 1985; Carneyetal. 19856; Grazianoe/a/. 1987;
Beplere/a/. 1987a,b). Since classic SCLCs express CKs,
while variant SCLCs may express NFs (Broers et al.
1985, 1986), we wondered whether such a progression
would be accompanied by a change or loss of IFPs. In
one of our cell lines (SCLC-16H), showing a progression
towards variant SCLC, a transition from CK to NF
expression was indeed seen.
Two cell lines (NL-SCLC3 and NCI-N417), which at
first did not express CKs or NFs, initiated the expression
of NFs upon prolonged culturing, suggesting that the
absence of CKs and NFs in some SCLC cell lines as well
as in some solid SCLC tumour parts (see also Broers et
al. 1987) may be a temporary event occurring in some
SCLC with a type of differentiation between classic and
variant, the so-called transitional type of SCLC (Bepler
et al. 1987a). In vitro the transitional cell type, in
contrast to the classic cell type, expresses vimentin.
Cytokeratin expression is found in varying degrees, and
neurofilaments are absent or barely demonstrable. It
remains to be determined to what extent the transitional
type of SCLC can be compared with the so-called
biochemical variant type of SCLC as defined by Gazdar
et al. (1985). Examination of IFP expression patterns in
these biochemical variant SCLC cell lines might eluci-
date this issue.
Another conversion that seems to occur within our cell
lines is that from variant SCLC to non-SCLC differen-
tiation, as described by Gazdar et al. (1981). In vitro
non-SCLC cell lines, which do not express the neuro-
endocrine-related biomarkers present in SCLC (Carney
et al. 1985a,b; Gazdar et al. 1985), grow as monolayers,
firmly attached to the surface of culturing flasks. By
selecting cells within the variant SCLC cell lines that
tended to attach, we were able to grow sublines consisting
of predominantly attached cells. Interestingly, these cells
lose the expression of the neuroendocrine marker MOC-1
(results not shown), and start to express CKs next to
NFs, resulting in a coexpression of CKs and NFs within
these cell lines or within individual cells. Whether these
cells lose the expression of other biomarkers, character-
istic of (variant) SCLC, remains to be examined.
As far as the implications of these findings can be
extrapolated to patient tumours it is important to note
that there is growing evidence of heterogeneity of lung
carcinomas. This heterogeneity can apparently also be
found in (some) lung cancer cell lines and, even more
interestingly, in cloned cell lines. Progression from
classic to variant SCLC has been reported in vivo
(Abeloff et al. 1979), especially after chemotherapy
and/or irradiation of patients. Also conversions from
SCLC to non-SCLC (Abeloff et al. 1979; Sehested et al.
1986) are often seen. In general, we can state that
conversions from one cell type to another within cell lines
are accompanied by a change in IFP expression patterns.
The conversions observed in the cell lines closely re-
semble those occurring in vivo. Therefore, our in vitro
findings strongly support the hypothesis that different
types of lung carcinomas may have a common origin (see
also Gazdar et al. 1981; McDowell & Trump, 1983) and
as a result heterogeneity in lung tumour types as well as
conversions from one tumour type to another are likely to
occur as a result of (trans)differentiation rather than
derivation (Gould, 1986).
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